Literature DB >> 32439002

Framingham General Cardiovascular Risk Score and Cognitive Impairment: The Power of Foresight.

Costantino Iadecola1, Neal S Parikh2.   

Abstract

Entities:  

Keywords:  Framingham General Cardiovascular Risk Score; cognitive decline; cohort study; magnetic resonance imaging; neurodegeneration; vascular lesions

Mesh：

Year:  2020        PMID： 32439002      PMCID： PMC7853244          DOI： 10.1016/j.jacc.2020.03.061

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  20 in total

1.  Sex differences in the association of Framingham Cardiac Risk Score with cognitive decline in community-dwelling elders without clinical heart disease.

Authors:  Gail A Laughlin; Linda K McEvoy; Denise von Mühlen; Lori B Daniels; Donna Kritz-Silverstein; Jaclyn Bergstrom; Kevin Cummins; Claudia Der-Martirosian; Simerjot K Jassal; Elizabeth Barrett-Connor
Journal:  Psychosom Med       Date:  2011-09-23       Impact factor: 4.312

2.  Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.

Authors:  Jennifer S Rabin; Aaron P Schultz; Trey Hedden; Anand Viswanathan; Gad A Marshall; Emily Kilpatrick; Hannah Klein; Rachel F Buckley; Hyun-Sik Yang; Michael Properzi; Vaishnavi Rao; Dylan R Kirn; Kathryn V Papp; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

Review 3.  Neurovascular and Cognitive Dysfunction in Hypertension.

Authors:  Costantino Iadecola; Rebecca F Gottesman
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

4.  ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial.

Authors:  Anne M Murray; Fang-Chi Hsu; Jeff D Williamson; R Nick Bryan; Hertzel C Gerstein; Mark D Sullivan; Michael E Miller; Iris Leng; Laura L Lovato; Lenore J Launer
Journal:  Diabetologia       Date:  2016-10-20       Impact factor: 10.122

5.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

Authors:  F Forette; M L Seux; J A Staessen; L Thijs; W H Birkenhäger; M R Babarskiene; S Babeanu; A Bossini; B Gil-Extremera; X Girerd; T Laks; E Lilov; V Moisseyev; J Tuomilehto; H Vanhanen; J Webster; Y Yodfat; R Fagard
Journal:  Lancet       Date:  1998-10-24       Impact factor: 79.321

Review 6.  Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association.

Authors:  Philip B Gorelick; Karen L Furie; Costantino Iadecola; Eric E Smith; Salina P Waddy; Donald M Lloyd-Jones; Hee-Joon Bae; Mary Ann Bauman; Martin Dichgans; Pamela W Duncan; Meighan Girgus; Virginia J Howard; Ronald M Lazar; Sudha Seshadri; Fernando D Testai; Stephen van Gaal; Kristine Yaffe; Hank Wasiak; Charlotte Zerna
Journal:  Stroke       Date:  2017-09-07       Impact factor: 7.914

7.  The effect of midlife cardiovascular risk factors on white matter hyperintensity volume and cognition two decades later in normal ageing women.

Authors:  Rowa Aljondi; Cassandra Szoeke; Chris Steward; Alexandra Gorelik; Patricia Desmond
Journal:  Brain Imaging Behav       Date:  2020-02       Impact factor: 3.978

8.  Cardiovascular risk factors and cognitive decline in adults aged 50 and over: a population-based cohort study.

Authors:  Alex Dregan; Robert Stewart; Martin C Gulliford
Journal:  Age Ageing       Date:  2012-11-25       Impact factor: 10.668

9.  Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study.

Authors:  Sara Kaffashian; Aline Dugravot; Hermann Nabi; G David Batty; Eric Brunner; Mika Kivimäki; Archana Singh-Manoux
Journal:  Eur Heart J       Date:  2011-05-23       Impact factor: 29.983

10.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2018-11-26       Impact factor: 44.182
View more
  2 in total

Review 1.  How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?

Authors:  Yu Kataoka; Sayaka Funabashi; Takahito Doi; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2022-01-13       Impact factor: 4.394

Review 2.  Establishing an oncocardiology service.

Authors:  L H Lehmann; M Totzeck
Journal:  Herz       Date:  2020-06-22       Impact factor: 1.443
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.